Renibus Therapeutics

About:

Renibus Therapeutics is a clinical-stage biotech company that focuses on preventing and treating kidney disease.

Twitter/X: renibusinc

Top Investors: Oxford Finance LLC

Description:

Renibus Therapeutics is a clinical-stage biotech company transforming outcomes in cardiothoracic surgical patients. It has developed a portfolio of products that activate multiple cytoprotective pathways, including organ protection via preconditioning.

Total Funding Amount:

$215M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Southlake, Texas, United States

Founded Date:

2016-01-01

Contact Email:

info(AT)renibus.com

Founders:

Alvaro Guillem, D. Jeffrey Keyser

Number of Employees:

11-50

Last Funding Date:

2023-09-12

IPO Status:

Private

Industries: